Name | Number of supported studies | Average coverage | |
---|---|---|---|
precursor B cell | 3 studies | 27% ± 5% |
Insufficient scRNA-seq data for expression of HRK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 489.34 | 2520 / 2642 | 93% | 5.93 | 653 / 705 |
thymus | 88% | 96.47 | 575 / 653 | 84% | 6.92 | 507 / 605 |
skin | 28% | 38.02 | 515 / 1809 | 78% | 9.37 | 366 / 472 |
eye | 0% | 0 | 0 / 0 | 94% | 5.75 | 75 / 80 |
adrenal gland | 28% | 28.92 | 73 / 258 | 52% | 2.49 | 120 / 230 |
breast | 48% | 34.42 | 219 / 459 | 18% | 0.81 | 198 / 1118 |
spleen | 51% | 28.66 | 123 / 241 | 0% | 0 | 0 / 0 |
kidney | 26% | 22.79 | 23 / 89 | 25% | 2.13 | 224 / 901 |
ovary | 2% | 3.01 | 4 / 180 | 48% | 1.98 | 208 / 430 |
esophagus | 27% | 26.07 | 383 / 1445 | 21% | 0.68 | 39 / 183 |
uterus | 10% | 5.66 | 17 / 170 | 37% | 1.65 | 172 / 459 |
lung | 25% | 18.69 | 147 / 578 | 12% | 0.33 | 141 / 1155 |
intestine | 34% | 23.52 | 329 / 966 | 2% | 0.06 | 10 / 527 |
lymph node | 0% | 0 | 0 / 0 | 34% | 4.20 | 10 / 29 |
tonsil | 0% | 0 | 0 / 0 | 33% | 0.82 | 15 / 45 |
adipose | 32% | 39.46 | 391 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 24% | 30.15 | 220 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 23% | 13.59 | 304 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 6% | 3.10 | 19 / 328 | 8% | 0.17 | 14 / 178 |
bladder | 5% | 1.52 | 1 / 21 | 8% | 0.23 | 41 / 504 |
heart | 12% | 9.03 | 107 / 861 | 0% | 0 | 0 / 0 |
stomach | 6% | 2.62 | 21 / 359 | 6% | 0.12 | 18 / 286 |
prostate | 9% | 10.62 | 23 / 245 | 1% | 0.03 | 6 / 502 |
muscle | 8% | 4.36 | 66 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 3% | 0.13 | 12 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
GO_0006915 | Biological process | apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | HRK |
Protein name | Activator of apoptosis harakiri (BH3-interacting domain-containing protein 3) (Neuronal death protein DP5) Harakiri, BCL2 interacting protein |
Synonyms | BID3 |
Description | FUNCTION: Promotes apoptosis. . |
Accessions | O00198 ENST00000550505.5 ENST00000257572.5 K7EJY7 |